Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bu/Cy/Flu Conditioning for Allogeneic SCT in Hematologic Malignancies
NCT00208923Phase 2Completed
- Sponsor
- Emory University
- Start
- Jul 1998
- Primary completion
- Oct 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), chronic lymphocytic leukemia (CLL), sponsored by Emory University. Started Jul 1998; status: completed.
02
Drugs
fludarabine
03
Conditions
chronic myeloid leukemia (CML)acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00208923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208923.